BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 31723780)

  • 1. A Novel Inducible Mouse Model of
    Stavropoulou V; Almosailleakh M; Royo H; Spetz JF; Juge S; Brault L; Kopp P; Iacovino M; Kyba M; Tzankov A; Stadler MB; Cazzaniga G; Peters AHFM; Schwaller J
    Hemasphere; 2018 Aug; 2(4):e51. PubMed ID: 31723780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MLL-ENL-mediated leukemia initiation at the interface of lymphoid commitment.
    Ugale A; Säwén P; Dudenhöffer-Pfeifer M; Wahlestedt M; Norddahl GL; Bryder D
    Oncogene; 2017 Jun; 36(22):3207-3212. PubMed ID: 28068328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficiency of murine MLL-ENL-driven leukemia initiation changes with age and peaks during neonatal development.
    Okeyo-Owuor T; Li Y; Patel RM; Yang W; Casey EB; Cluster AS; Porter SN; Bryder D; Magee JA
    Blood Adv; 2019 Aug; 3(15):2388-2399. PubMed ID: 31405949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The oncoprotein MLL-ENL disturbs hematopoietic lineage determination and transforms a biphenotypic lymphoid/myeloid cell.
    Zeisig BB; García-Cuéllar MP; Winkler TH; Slany RK
    Oncogene; 2003 Mar; 22(11):1629-37. PubMed ID: 12642866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MLL-ENL causes a reversible and myc-dependent block of myelomonocytic cell differentiation.
    Schreiner S; Birke M; García-Cuéllar MP; Zilles O; Greil J; Slany RK
    Cancer Res; 2001 Sep; 61(17):6480-6. PubMed ID: 11522644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional characterization of high levels of meningioma 1 as collaborating oncogene in acute leukemia.
    Liu T; Jankovic D; Brault L; Ehret S; Baty F; Stavropoulou V; Rossi V; Biondi A; Schwaller J
    Leukemia; 2010 Mar; 24(3):601-12. PubMed ID: 20072157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hematopoietic stem cells are intrinsically protected against MLL-ENL-mediated transformation.
    Ugale A; Norddahl GL; Wahlestedt M; Säwén P; Jaako P; Pronk CJ; Soneji S; Cammenga J; Bryder D
    Cell Rep; 2014 Nov; 9(4):1246-55. PubMed ID: 25456127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MLL-ENL cooperates with SCF to transform primary avian multipotent cells.
    Schulte CE; von Lindern M; Steinlein P; Beug H; Wiedemann LM
    EMBO J; 2002 Aug; 21(16):4297-306. PubMed ID: 12169632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mll fusions generated by Cre-loxP-mediated de novo translocations can induce lineage reassignment in tumorigenesis.
    Drynan LF; Pannell R; Forster A; Chan NM; Cano F; Daser A; Rabbitts TH
    EMBO J; 2005 Sep; 24(17):3136-46. PubMed ID: 16096649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcome and monitoring of minimal residual disease in patients with acute lymphoblastic leukemia expressing the MLL/ENL fusion gene.
    Elia L; Grammatico S; Paoloni F; Vignetti M; Rago A; Cenfra N; Mecarocci S; Mancini M; Luciani M; Di Raimondo F; Cazzaniga G; Matarazzo M; Moleti ML; Santoro L; Gaidano G; Foà R; Mandelli F; Cimino G
    Am J Hematol; 2011 Dec; 86(12):993-7. PubMed ID: 21953510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of acute leukemias with MLL/ENL fusion transcripts: identification of two novel breakpoints in ENL.
    Fu JF; Liang DC; Shih LY
    Am J Clin Pathol; 2007 Jan; 127(1):24-30. PubMed ID: 17145626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complex MLL rearrangement in a patient with T-cell acute lymphoblastic leukemia.
    Chervinsky DS; Sait SN; Nowak NJ; Shows TB; Aplan PD
    Genes Chromosomes Cancer; 1995 Sep; 14(1):76-84. PubMed ID: 8527389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRISPR-Cas9-induced t(11;19)/MLL-ENL translocations initiate leukemia in human hematopoietic progenitor cells
    Reimer J; Knöß S; Labuhn M; Charpentier EM; Göhring G; Schlegelberger B; Klusmann JH; Heckl D
    Haematologica; 2017 Sep; 102(9):1558-1566. PubMed ID: 28572162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A proteolysis-targeting chimera molecule selectively degrades ENL and inhibits malignant gene expression and tumor growth.
    Li X; Yao Y; Wu F; Song Y
    J Hematol Oncol; 2022 Apr; 15(1):41. PubMed ID: 35395864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Childhood acute lymphoblastic leukemia with the MLL-ENL fusion and t(11;19)(q23;p13.3) translocation.
    Rubnitz JE; Camitta BM; Mahmoud H; Raimondi SC; Carroll AJ; Borowitz MJ; Shuster JJ; Link MP; Pullen DJ; Downing JR; Behm FG; Pui CH
    J Clin Oncol; 1999 Jan; 17(1):191-6. PubMed ID: 10458233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immortalization and leukemic transformation of a myelomonocytic precursor by retrovirally transduced HRX-ENL.
    Lavau C; Szilvassy SJ; Slany R; Cleary ML
    EMBO J; 1997 Jul; 16(14):4226-37. PubMed ID: 9250666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cooperative gene activation by AF4 and DOT1L drives MLL-rearranged leukemia.
    Okuda H; Stanojevic B; Kanai A; Kawamura T; Takahashi S; Matsui H; Takaori-Kondo A; Yokoyama A
    J Clin Invest; 2017 May; 127(5):1918-1931. PubMed ID: 28394257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Mll-Een knockin fusion gene enhances proliferation of myeloid progenitors derived from mouse embryonic stem cells and causes myeloid leukaemia in chimeric mice.
    Kong CT; Sham MH; So CW; Cheah KS; Chen SJ; Chan LC
    Leukemia; 2006 Oct; 20(10):1829-39. PubMed ID: 16888613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ENL moiety of the childhood leukemia-associated MLL-ENL oncoprotein recruits human Polycomb 3.
    García-Cuéllar MP; Zilles O; Schreiner SA; Birke M; Winkler TH; Slany RK
    Oncogene; 2001 Jan; 20(4):411-9. PubMed ID: 11313972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ZNF521 sustains the differentiation block in MLL-rearranged acute myeloid leukemia.
    Germano G; Morello G; Aveic S; Pinazza M; Minuzzo S; Frasson C; Persano L; Bonvini P; Viola G; Bresolin S; Tregnago C; Paganin M; Pigazzi M; Indraccolo S; Basso G
    Oncotarget; 2017 Apr; 8(16):26129-26141. PubMed ID: 28412727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.